Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at ...
Study evaluates the brain-penetrant PI3K/mTOR inhibitor in treatment-resistant epilepsy associated with focal cortical ...
Viva-Thera combines atomic-resolution structural research with XtalPi’s AI and automation platform to pursue HIV prevention, ...
Expansion Opportunity Beyond Dercum's Disease—Study findings support the potential development of CBL-514 for Lipedema, a ...
Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, announced ...
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of ...
Antibody expression: Tsingke works with multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with ...
Exclusive agreement adds BoomRay’s preclinical RLT programme to Novartis’ oncology pipeline, with potential milestone ...
European Commission authorisation marks the first global regulatory approval for obicetrapib, offering new oral, non-statin ...
GenScript Biotech subsidiary targets commercial-scale sugar reduction with 100-tonne annual capacity for Mellia® Brazzein, ...
Figure 1. The 2026 approvals timeline: one dot per new active substance, by month and authority. Solid dots are ...
The Singapore site serves as a core cornerstone of WuXi XDC's commercial manufacturing, spanning approximately 25,000 square meters. The site's BCM3 dual-function production line and DP4 conjugated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results